Article
Developmental safety of nirmatrelvir in zebrafish (Danio rerio) embryos
14 Nov 2022
Abstract excerpt
BACKGROUND: Nirmatrelvir, in combination with ritonavir, is one of the first orally available antiviral treatment for coronavirus disease 2019 (COVID-19). Symptomatic pregnant women are at increased risk for severe illness and complications that can affect the developing baby. No malformations or lower embryo-fetal survival have been observed when nirmatrelvir were administered to pregnant rats and rabbits....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
